There are many treatment options for patients with adult brain tumors. At Moffitt we offer an individualized interdisciplinary team approache for brain cancer treatment options to breakthrough clinical trials, Moffitt’s neuro-oncology team will guide you and your family in choosing the option that provides the best path of treatment and recovery.
Moffitt Cancer Center's brain cancer treatment options include surgery, radiation therapy and chemotherapy. In our state-of-the-art neuro-surgery suites, surgeons are guided using a 3-D intra-operative navigation system that provides them with a road map of the tumor and surrounding tissue to help avoid damage of healthy tissues. This system also helps the team precisely locate deep-seated or smaller tumors. In addition, surgeons can follow their patients’ surgery by monitoring their speech while awake during critical parts of the procedure. Neurosurgeons also implant slow-released, biodegradable chemotherapy wafers. Remifentanil is a fast-acting anesthesia agent that helps the patient wake up quickly after a procedure for immediate postoperative assessment and a shorter hospital stay. Many neurosurgical patients are discharged in 1 to 2 days.
There are two types of radiation therapy: internal and external. Radiation therapy chosen depends upon the type of brain tumor, its stage and location. Our expert team of radiation oncologists use leading-edge therapies such as three-dimensional conformal radiation therapy, stereotactic radiosurgery and intensity-modulated radiation therapy.
The most common types of chemotherapy agents used to treat brain tumors are carmustine (BCNU), lomustine (CCNU), procarbazine, cisplatinum, carboplatin, vincristine, methotrexate and temozolomide. The agents can be delivered intravenously, orally or in slow-release wafers, and are often used in conjunction with other brain cancer treatment therapies.
As part of our commitment to Total Cancer Care®, we also use bio, immuno, hormone and gene therapies to pair specific treatments with the unique footprint of each patient’s brain cancer. Biological response modifiers include anti-angiogenesis, antisense therapy, differentiators, gene therapy, growth factors, interferon, interleukins, anti-estrogen or antiprogesterone receptors.